. Medical and Hospital News .




.
EPIDEMICS
Health experts, scientists to discuss bird flu studies
by Staff Writers
Geneva (AFP) Feb 10, 2012


The World Health Organization said Friday it will meet next week to determine whether scientists can publish research on a bird flu virus that may be easily passed among humans.

The two-day discussion will relate to research on a mutation of the H5N1 virus that international scientists halted on January 20 citing fears of the devastation it could wreak were it to escape the laboratory.

According to WHO, avian influenza H5N1 is primarily transmitted between birds, and very rarely to humans.

Two separate teams of researchers, one in the Netherlands and the other in the United States, found ways late last year to engineer the H5N1 virus so that it is transmitted among mammals, something that has been rare.

The breakthrough raised alarm that the method could fall into the wrong hands and unleash a massive flu pandemic that could cost millions of lives.

A US advisory panel in December urged that key details remain unpublished.

WHO said it will hold a technical meeting on Wednesday and Thursday on the specific circumstances and results of the two studies.

"There will be 22 participants: two teams of researchers, representatives of the influenza laboratory network and representatives of the scientific newspapers Science and Nature" said WHO spokeswoman Fadela Chaib.

They will try to reach a consensus about practical actions to resolve the most urgent issues, particularly those related to access to and dissemination of the results of this research, WHO said.

Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola




.
.
Get Our Free Newsletters Via Email
...
Buy Advertising Editorial Enquiries




.

. Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle



EPIDEMICS
S.Africa announces AIDS drug venture with Swiss Lonza
Cape Town (AFP) Feb 10, 2012
South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs. Lonza, headquartered in Basel, confirmed talks with the South African government but said no deal had yet been inked. "This joint venture, named Ketlaphela, will establish the first pharmaceu ... read more


EPIDEMICS
Japan's Fukushima reactor may be reheating: operator

Top US general meets Egypt's Tantawi amid NGOs row

Bird numbers drop around Fukushima

Japan passes $33 bln fourth extra budget

EPIDEMICS
GPS court ruling leaves US phone tracking unclear

Russia May Spend Almost $12 bln on Glonass in 2012-2020

EPIDEMICS
Neanderthal demise due to many influences, including cultural changes

Why the brain is more reluctant to function as we age

Cutting-edge MRI techniques for studying communication within the brain

Entire genome of extinct human decoded from fossil

EPIDEMICS
Fruit flies drawn to the sweet smell of youth

How the zebra got its stripes

Genetic Rosetta Stone unveiled in Nature

Coaxing a Shy Microbe to Stand Out in a Crowd

EPIDEMICS
Flight from Japan sparks New Zealand flu scare

Health experts, scientists to discuss bird flu studies

S.Africa announces AIDS drug venture with Swiss Lonza

EPIDEMICS
China police officer killed in Tibetan area: state media

Tibetan nun self-immolates in China: rights groups

Chinese village experiments with democracy

Police chief flies to Beijing amid defection rumours

EPIDEMICS
Pirates kill captain, engineer in attack off Nigeria: IMB

EPIDEMICS
Greece backs austerity measures, Athens counts cost

Myanmar MPs tackle first budget in decades

Honduras inching back to economic recovery

China city offers housing subsidies to boost sales


Memory Foam Mattress Review

Newsletters :: SpaceDaily Express :: SpaceWar Express :: TerraDaily Express :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News

.

The content herein, unless otherwise known to be public domain, are Copyright 1995-2012 - Space Media Network. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement